NL7510104A - Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat. - Google Patents

Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.

Info

Publication number
NL7510104A
NL7510104A NL7510104A NL7510104A NL7510104A NL 7510104 A NL7510104 A NL 7510104A NL 7510104 A NL7510104 A NL 7510104A NL 7510104 A NL7510104 A NL 7510104A NL 7510104 A NL7510104 A NL 7510104A
Authority
NL
Netherlands
Prior art keywords
preparation
active pharmaceutical
oral active
pharmaceutical preparation
oral
Prior art date
Application number
NL7510104A
Other languages
English (en)
Dutch (nl)
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Priority to NL7510104A priority Critical patent/NL7510104A/xx
Priority to IE1778/76A priority patent/IE44533B1/en
Priority to ZA764868A priority patent/ZA764868B/xx
Priority to US05/714,454 priority patent/US4083973A/en
Priority to IL50274A priority patent/IL50274A/xx
Priority to GB34253/76A priority patent/GB1563302A/en
Priority to AU16980/76A priority patent/AU508727B2/en
Priority to LU75648A priority patent/LU75648A1/xx
Priority to HU76AO441A priority patent/HU176743B/hu
Priority to JP51101474A priority patent/JPS5231063A/ja
Priority to GR51544A priority patent/GR70296B/el
Priority to CA259,950A priority patent/CA1092025A/en
Priority to FR7625795A priority patent/FR2321892A1/fr
Priority to DE19762638507 priority patent/DE2638507A1/de
Priority to NZ181865A priority patent/NZ181865A/xx
Priority to PH7618840A priority patent/PH12363A/en
Priority to BE170156A priority patent/BE845613A/xx
Publication of NL7510104A publication Critical patent/NL7510104A/xx
Priority to CA365,887A priority patent/CA1113926A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NL7510104A 1975-08-27 1975-08-27 Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat. NL7510104A (nl)

Priority Applications (18)

Application Number Priority Date Filing Date Title
NL7510104A NL7510104A (nl) 1975-08-27 1975-08-27 Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.
IE1778/76A IE44533B1 (en) 1975-08-27 1976-08-11 Oral pharmaceutical preparation with anabolic activity containing a 17 - ester of nandrolone
ZA764868A ZA764868B (en) 1975-08-27 1976-08-12 Novel pharmaceutical preparation adapted for oral administration
US05/714,454 US4083973A (en) 1975-08-27 1976-08-16 Pharmaceutical preparation adapted for oral administration
IL50274A IL50274A (en) 1975-08-27 1976-08-16 Oral pharmaceutical preparations with anabolic activity comprising esters of nandrolone
GB34253/76A GB1563302A (en) 1975-08-27 1976-08-17 Oral pharmaceutical preparation with anabolic activity containing a 17 -ester of nandrolone
AU16980/76A AU508727B2 (en) 1975-08-27 1976-08-19 Nandrolone 17 beta ester compositions
JP51101474A JPS5231063A (en) 1975-08-27 1976-08-24 Production of novel 17 betaaester of nandrolone and novel pharmaceutical agent containing same with assimirating action
HU76AO441A HU176743B (en) 1975-08-27 1976-08-24 Process for preparing combined preparations with anabolic activity for oral application
LU75648A LU75648A1 (el) 1975-08-27 1976-08-24
GR51544A GR70296B (el) 1975-08-27 1976-08-25
CA259,950A CA1092025A (en) 1975-08-27 1976-08-26 Pharmaceutical preparation adapted for oral administration
FR7625795A FR2321892A1 (fr) 1975-08-27 1976-08-26 Preparations pharmaceutiques pour l'administration orale renfermant un ester-17b de nandrolone et nouveaux esters-17b de nandrolone
DE19762638507 DE2638507A1 (de) 1975-08-27 1976-08-26 Arzneimittel mit anabolischer wirksamkeit
NZ181865A NZ181865A (en) 1975-08-27 1976-08-26 Oral anabolic compositions containing certain 19-nortestosterone 17 -esters in contunction with a non-steriodal lipid
PH7618840A PH12363A (en) 1975-08-27 1976-08-27 Oral pharmaceutical compositions of nandrolone-17 esters with a non-steroidal lipoid
BE170156A BE845613A (fr) 1975-08-27 1976-08-27 Preparations pharmaceutiques pour l'administration orale renfermant un ester-17beta de nandrolone et nouveaux esters- 17beta de nandrolone
CA365,887A CA1113926A (en) 1975-08-27 1980-12-01 Pharmaceutical preparation adapted for oral administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7510104A NL7510104A (nl) 1975-08-27 1975-08-27 Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.

Publications (1)

Publication Number Publication Date
NL7510104A true NL7510104A (nl) 1977-03-01

Family

ID=19824362

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7510104A NL7510104A (nl) 1975-08-27 1975-08-27 Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.

Country Status (17)

Country Link
US (1) US4083973A (el)
JP (1) JPS5231063A (el)
AU (1) AU508727B2 (el)
BE (1) BE845613A (el)
CA (1) CA1092025A (el)
DE (1) DE2638507A1 (el)
FR (1) FR2321892A1 (el)
GB (1) GB1563302A (el)
GR (1) GR70296B (el)
HU (1) HU176743B (el)
IE (1) IE44533B1 (el)
IL (1) IL50274A (el)
LU (1) LU75648A1 (el)
NL (1) NL7510104A (el)
NZ (1) NZ181865A (el)
PH (1) PH12363A (el)
ZA (1) ZA764868B (el)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0177342A2 (en) * 1984-10-04 1986-04-09 Genentech, Inc. Oral formulation of therapeutic proteins

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
FR2427100A1 (fr) * 1978-06-02 1979-12-28 Kali Chemie Pharma Gmbh Composition pharmaceutique a propriete de resorption amelioree et procede pour sa fabrication
US5140021A (en) * 1986-04-16 1992-08-18 Genesis Systems Corporation Method and dosage form for treatment of premenstrual syndrome
US5208032A (en) * 1988-07-15 1993-05-04 Rutgers, The State University Of New Jersey Increasing the growth of turkeys using implant of 19-nortestosterone
ATE333867T1 (de) * 1994-03-18 2006-08-15 Shire Lab Inc Emulgierte arzneistoffabgabesysteme
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US6011027A (en) * 1999-02-18 2000-01-04 Lpj Research, Inc. Use of 19-nor-4-androstenediol to increase 19-nortestosterone levels in humans
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
JP4995407B2 (ja) 2002-04-25 2012-08-08 バナー ファーマキャップス， インコーポレーテッド 咀嚼可能なソフトカプセル
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
EP1530965B1 (en) 2003-11-11 2006-03-08 Mattern, Udo Controlled release delivery system of sexual hormones for nasal application
CN1257711C (zh) * 2003-12-05 2006-05-31 石药集团中奇制药技术（石家庄）有限公司 丁苯酞软胶囊及其制备工艺
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
AU2006299833B2 (en) 2005-10-12 2012-04-12 Besins Healthcare Luxembourg Sarl Improved testosterone gel and method of use
MX2009003654A (es) 2006-10-04 2009-04-22 M & P Patent Ag Sistema de suministro por liberacion controlada para la aplicacion nasal de neurotransmisores.
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
CA2950670A1 (en) 2014-06-17 2015-12-23 Merck Sharp & Dohme B.V. Stable formulations of testosterone undecanoate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2998423A (en) * 1958-02-25 1961-08-29 Organon Esters of 19-nortestosterone
US3016388A (en) * 1959-06-30 1962-01-09 Organon New esters of 19-nor-testosterone
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0177342A2 (en) * 1984-10-04 1986-04-09 Genentech, Inc. Oral formulation of therapeutic proteins
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins

Also Published As

Publication number Publication date
IL50274A (en) 1980-11-30
FR2321892A1 (fr) 1977-03-25
CA1092025A (en) 1980-12-23
BE845613A (fr) 1977-02-28
DE2638507A1 (de) 1977-03-03
IE44533B1 (en) 1981-12-30
LU75648A1 (el) 1977-03-31
HU176743B (en) 1981-05-28
IL50274A0 (en) 1976-10-31
AU508727B2 (en) 1980-04-03
FR2321892B1 (el) 1979-05-25
AU1698076A (en) 1978-02-23
JPS5231063A (en) 1977-03-09
ZA764868B (en) 1977-07-27
NZ181865A (en) 1978-12-18
GR70296B (el) 1982-09-06
PH12363A (en) 1979-01-29
IE44533L (en) 1977-02-27
GB1563302A (en) 1980-03-26
US4083973A (en) 1978-04-11

Similar Documents

Publication Publication Date Title
NL7506407A (nl) Werkwijze ter bereiding van een oraal werkzaam far- maceutisch preparaat.
NL7510104A (nl) Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.
NL7603448A (nl) Werkwijze voor de bereiding van carbodiimiden.
NL166460C (nl) Werkwijze voor de bereiding van zeer zuiver tereftaalzuur.
NL7608946A (nl) Werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat, alsmede werkwijze ter bereiding van pyrrolidine- verbindingen.
NL182217C (nl) Werkwijze voor de bereiding van 2-oxo-3-arylpropionzuur.
NL7614538A (nl) Werkwijze ter bereiding van farmacologisch actieve heterocyclische verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
NL161462B (nl) Werkwijze ter bereiding van een farmaceutisch preparaat en werkwijze ter bereiding van daarvoor geschikte verbindingen.
NL7602716A (nl) Werkwijze voor de bereiding van salicylanilide- derivaten.
NL7606089A (nl) Werkwijze voor de bereiding van een zuur protease.
NL7608496A (nl) Werkwijze ter bereiding van farmacologisch actieve verbindingen alsmede farmaceutische preparaten die deze verbindingen bevatten.
NL186575C (nl) Werkwijze ter bereiding van aminoalkaan-1,1-difosfonzuren, alsmede werkwijze ter bereiding van een farmaceutisch of cosmetisch preparaat.
NL7607368A (nl) Werkwijze voor de bereiding van een aldohexu- ronzuur bevattende zoetstof.
NL7606994A (nl) Werkwijze voor de bereiding van acylcyaniden.
NL7606824A (nl) Werkwijze voor het bereiden van een oraal preparaat.
NL7606906A (nl) Werkwijze voor de bereiding van thymol.
NL7610359A (nl) Werkwijze voor de bereiding van alkenen.
NL7513230A (nl) Werkwijze voor de bereiding van farmaceutische tabletten.
NL7610059A (nl) Werkwijze voor de bereiding van 4-oxo-4h-benzo- pyranderivaten.
NL7600512A (nl) Werkwijze voor de bereiding van 2-aminobutanol-1.
NL7610057A (nl) Werkwijze voor de bereiding van farmaceutische preparaten.
NL7608796A (nl) Werkwijze voor de bereiding van oxyranderivaten.
NL7603449A (nl) Werkwijze voor de bereiding van (alpha)-fenylpropion- zuren.
NL184952C (nl) Werkwijze voor de bereiding van cyclohexanonoxim.
NL7607616A (nl) Werkwijze voor de bereiding van lactonen.

Legal Events

Date Code Title Description
BV The patent application has lapsed